Literature DB >> 1709770

High-dose intravenous gammaglobulin therapy for neonatal immune haemolytic jaundice due to blood group incompatibility.

K Sato1, T Hara, T Kondo, H Iwao, S Honda, K Ueda.   

Abstract

Three newborn infants who developed hyperbilirubinemia due to blood group incompatibility were treated with high-dose gammaglobulin. Hyperbilirubinemia was caused by Rhesus (Rh) incompatibility (anti-E + anti-c) in Infant 1 and ABO incompatibility (anti-B) in Infants 2 and 3. Hyperbilirubinemia was refractory to conventional phototherapy but responded well to intravenous gammaglobulin (IVGG) at a dose of 1 g/kg in all infants. No adverse effects were observed. These findings suggest that high-dose IVGG may be useful in the treatment of hyperbilirubinemia due to isoimmune haemolytic disease resistant to phototherapy.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1709770     DOI： 10.1111/j.1651-2227.1991.tb11828.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN： 0001-656X


  5 in total

1.  Addressing hemolysis in an infant due to mother-infant ABO blood incompatibility.

Authors:  Sandra Martin; Rebecca N Jerome; Marcia I Epelbaum; Annette M Williams; William Walsh
Journal:  J Med Libr Assoc       Date:  2008-07

2.  Exchange transfusion for hemolytic hyperbilirubinemia: could some be averted by emergent administration of an inhibitor of bilirubin production?

Authors:  Susan E Wiedmeier; Timothy M Bahr; Robin K Ohls; Thomas R Christensen; Vickie L Baer; Sarah J Ilstrup; Kelly Cail; Robert D Christensen
Journal:  J Perinatol       Date:  2020-07-15       Impact factor: 2.521

3.  Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion.

Authors:  Emel Okulu; Omer Erdeve; Ilknur Kilic; Ozgur Olukman; Sebnem Calkavur; Gokhan Buyukkale; Merih Cetinkaya; Dilek Ulubas; Nihal Demirel; Deniz Hanta; Sabahattin Ertugrul; Nazli Dilay Gultekin; Oguz Tuncer; Nihat Demir; Leyla Bilgin; Nejat Narli; Duran Yildiz; Demet Terek; Ozge Altun Koroglu; Canan Seren; Elif Ozyazici; Ramazan Ozdemir; Hatice Turgut; Fatma Narter; Yasemin Akin; Ahmet Ozyazici; Aysegul Zenciroglu; Huseyin Selim Asker; Zeynel Gokmen; Musa Salihli; Ali Bulbul; Umut Zubarioglu; Begum Atasay; Esin Koc
Journal:  Front Pediatr       Date:  2022-04-28       Impact factor: 3.418

Review 4.  Hyperbilirubinemia in Neonates: Types, Causes, Clinical Examinations, Preventive Measures and Treatments: A Narrative Review Article.

Authors:  Sana Ullah; Khaista Rahman; Mehdi Hedayati
Journal:  Iran J Public Health       Date:  2016-05       Impact factor: 1.429

Review 5.  Immunoglobulin for alloimmune hemolytic disease in neonates.

Authors:  Carolien Zwiers; Mirjam Ea Scheffer-Rath; Enrico Lopriore; Masja de Haas; Helen G Liley
Journal:  Cochrane Database Syst Rev       Date:  2018-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.